Protein Degradation

This report explores the rapid advancement of targeted protein degraders as a high-potential modality, including trends, challenges, and leading biotech innovators.

Key takeaways:

• Strong deal activity and investment momentum
• Six innovative biotech leaders identified
• Broad applications across multiple disease areas
• Key innovation drivers include PROTACs, molecular glues, and AI
• Ongoing challenges in clinical translation and regulation
• Importance of differentiation and strong IP